STRONGBRIDGE U.S. INC. EXECUTIVE CHAIRMAN AGREEMENTExecutive Chairman Agreement • February 28th, 2020 • Strongbridge Biopharma PLC • Pharmaceutical preparations • Pennsylvania
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionThis Executive Chairman Agreement (the “Agreement”) is made and entered into as of November 1, 2019 (the “Effective Date”), between Strongbridge Biopharma plc (“Strongbridge”), Strongbridge U.S. Inc., a Delaware corporation (the “Company”), and John Johnson (the “Executive”).
STRONGBRIDGE BIOPHARMA PLC AMENDMENT TO OPTION AWARD AGREEMENTSOption Award Agreement • February 28th, 2020 • Strongbridge Biopharma PLC • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company IndustryThis AMENDMENT TO OPTION AWARD AGREEMENTS (this “Agreement”) dated as of November 26, 2019, is entered into by and between Strongbridge Biopharma plc (the “Company”) and Matthew Pauls (the “Grantee”).
DatedIndemnification Agreement • February 28th, 2020 • Strongbridge Biopharma PLC • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2020 Company IndustryTHIS DEED OF INDEMNIFICATION (this “Agreement”), dated as of [____________], is made by and between Strongbridge Biopharma public limited company, an Irish public limited company (“Strongbridge”) and [____________] (the “Indemnitee”).
STRONGBRIDGE BIOPHARMA PLC NON-EMPLOYEE DIRECTOR EQUITY COMPENSATION PLANRestricted Stock Unit Award Agreement • February 28th, 2020 • Strongbridge Biopharma PLC • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionThis RESTRICTED STOCK UNIT AWARD AGREEMENT (the “Agreement”), dated as of [Date] (the “Date of Grant”) is delivered by Strongbridge Biopharma plc (the “Company”), to [Name] (the “Grantee”).